Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-dexrazoxane | multiple interactions | EXP | | 6480464 | [Doxorubicin co-treated with Dexrazoxane] results in increased expression of SLC25A34 mRNA | CTD | PMID:26873546 | 1,2-dichloroethane | decreases expression | EXP | | 6480464 | ethylene dichloride results in decreased expression of SLC25A34 mRNA | CTD | PMID:28960355 | 1-Hydroxypyrene | decreases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | 1-hydroxypyrene results in decreased expression of SLC25A34 mRNA | CTD | PMID:21854004 | 17beta-estradiol | decreases expression | ISO | Slc25a34 (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of SLC25A34 mRNA | CTD | PMID:32145629 | 2,2',5,5'-tetrachlorobiphenyl | increases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:36804509 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Slc25a34 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC25A34 mRNA | CTD | PMID:33387578 | 4,4'-sulfonyldiphenol | increases methylation | EXP | | 6480464 | bisphenol S results in increased methylation of SLC25A34 exon | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | affects methylation | EXP | | 6480464 | bisphenol S affects the methylation of SLC25A34 gene | CTD | PMID:31683443 | 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of SLC25A34 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | ISO | Slc25a34 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of SLC25A34 mRNA | CTD | PMID:24780913 | acrylamide | decreases expression | ISO | Slc25a34 (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of SLC25A34 mRNA | CTD | PMID:28959563 | aflatoxin B1 | decreases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of SLC25A34 mRNA | CTD | PMID:32234424 | all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC25A34 mRNA | CTD | PMID:36189433 | aristolochic acid A | increases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of SLC25A34 mRNA | CTD | PMID:33212167 | arsane | affects methylation | ISO | SLC25A34 (Homo sapiens) | 6480464 | Arsenic affects the methylation of SLC25A34 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | SLC25A34 (Homo sapiens) | 6480464 | Arsenic affects the methylation of SLC25A34 gene | CTD | PMID:25304211 | benzo[a]pyrene | increases methylation | ISO | SLC25A34 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SLC25A34 exon | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of SLC25A34 mRNA | CTD | PMID:32234424 | bisphenol A | decreases expression | ISO | Slc25a34 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SLC25A34 mRNA | CTD | PMID:25181051 and PMID:32145629 | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | ciprofibrate | increases expression | EXP | | 6480464 | ciprofibrate results in increased expression of SLC25A34 mRNA | CTD | PMID:27225895 | ciprofibrate | increases expression | ISO | Slc25a34 (Rattus norvegicus) | 6480464 | ciprofibrate results in increased expression of SLC25A34 mRNA | CTD | PMID:27225895 | dibenz[a,h]anthracene | increases expression | EXP | | 6480464 | 1 more ... | CTD | PMID:26377693 | dichloroacetic acid | increases expression | EXP | | 6480464 | Dichloroacetic Acid results in increased expression of SLC25A34 mRNA | CTD | PMID:28962523 | dimethylselenide | multiple interactions | ISO | SLC25A34 (Homo sapiens) | 6480464 | [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of SLC25A34-AS1 mRNA] which results in increased expression of SLC25A34 mRNA | CTD | PMID:33656867 | dioxygen | multiple interactions | EXP | | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC25A34 mRNA | CTD | PMID:30529165 | doxorubicin | multiple interactions | EXP | | 6480464 | [Doxorubicin co-treated with Dexrazoxane] results in increased expression of SLC25A34 mRNA | CTD | PMID:26873546 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SLC25A34 mRNA | CTD | PMID:26873546 | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of SLC25A34 mRNA | CTD | PMID:30319688 | fenofibrate | increases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | Fenofibrate results in increased expression of SLC25A34 mRNA | CTD | PMID:25572481 | formaldehyde | decreases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of SLC25A34 mRNA | CTD | PMID:27905399 | mono(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of SLC25A34 mRNA | CTD | PMID:36189433 | mono(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC25A34 mRNA | CTD | PMID:36189433 | Muraglitazar | increases expression | ISO | Slc25a34 (Rattus norvegicus) | 6480464 | muraglitazar results in increased expression of SLC25A34 mRNA | CTD | PMID:21515302 | N-Nitrosopyrrolidine | decreases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in decreased expression of SLC25A34 mRNA | CTD | PMID:32234424 | nickel atom | decreases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | Nickel results in decreased expression of SLC25A34 mRNA | CTD | PMID:24768652 | O-methyleugenol | decreases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of SLC25A34 mRNA | CTD | PMID:32234424 | ozone | multiple interactions | ISO | SLC25A34 (Homo sapiens) | 6480464 | [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of SLC25A34-AS1 mRNA] which results in increased expression of SLC25A34 mRNA and [Air Pollutants results in increased abundance of Ozone] which affects the expression of SLC25A34 mRNA | CTD | PMID:33656867 and PMID:35430440 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of SLC25A34 mRNA | CTD | PMID:17562736 | perfluoroheptanoic acid | increases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | perfluoro-n-heptanoic acid results in increased expression of SLC25A34 mRNA | CTD | PMID:23567314 | perfluorohexanoic acid | increases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | perfluorohexanoic acid results in increased expression of SLC25A34 mRNA | CTD | PMID:23567314 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of SLC25A34 mRNA | CTD | PMID:23567314 | perfluorooctanoic acid | increases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of SLC25A34 mRNA | CTD | PMID:23567314 | perfluorooctanoic acid | increases expression | ISO | Slc25a34 (Rattus norvegicus) | 6480464 | perfluorooctanoic acid results in increased expression of SLC25A34 mRNA | CTD | PMID:28511854 | perfluoroundecanoic acid | increases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | perfluoroundecanoic acid results in increased expression of SLC25A34 mRNA | CTD | PMID:23567314 | pioglitazone | multiple interactions | EXP | | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLC25A34 mRNA | CTD | PMID:27935865 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of SLC25A34 mRNA | CTD | PMID:25270620 | pravastatin | affects expression | ISO | Slc25a34 (Rattus norvegicus) | 6480464 | Pravastatin affects the expression of SLC25A34 mRNA | CTD | PMID:27225895 | propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of SLC25A34 mRNA | CTD | PMID:21278054 | rifampicin | decreases expression | ISO | SLC25A34 (Homo sapiens) | 6480464 | Rifampin results in decreased expression of SLC25A34 mRNA | CTD | PMID:27199754 | Tesaglitazar | increases expression | ISO | Slc25a34 (Rattus norvegicus) | 6480464 | tesaglitazar results in increased expression of SLC25A34 mRNA | CTD | PMID:21515302 | tetrachloroethene | increases expression | EXP | | 6480464 | Tetrachloroethylene results in increased expression of SLC25A34 mRNA | CTD | PMID:28973375 | thioacetamide | decreases expression | ISO | Slc25a34 (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of SLC25A34 mRNA | CTD | PMID:34492290 | triptonide | increases expression | EXP | | 6480464 | triptonide results in increased expression of SLC25A34 mRNA | CTD | PMID:33045310 | troglitazone | increases expression | ISO | Slc25a34 (Rattus norvegicus) | 6480464 | troglitazone results in increased expression of SLC25A34 mRNA | CTD | PMID:21515302 | valproic acid | increases methylation | ISO | SLC25A34 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of SLC25A34 gene | CTD | PMID:29154799 | XL147 | multiple interactions | EXP | | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC25A34 mRNA | CTD | PMID:27935865 | zaragozic acid A | increases expression | EXP | | 6480464 | squalestatin 1 results in increased expression of SLC25A34 mRNA | CTD | PMID:27225895 | zaragozic acid A | increases expression | ISO | Slc25a34 (Rattus norvegicus) | 6480464 | squalestatin 1 results in increased expression of SLC25A34 mRNA | CTD | PMID:27225895 | |